- Modifiable risk factors of COVID|19 in patients with multiple sclerosis🔍
- Modifiable Risk Factors of COVID|19 in Patients with Multiple Sclerosis🔍
- Underlying Conditions and the Higher Risk for Severe COVID|19🔍
- Risk of Getting COVID|19 in People With Multiple Sclerosis🔍
- SARS|CoV|2 Infection in a North American Registry of Patients With ...🔍
- Multiple Sclerosis and COVID|19 Risk Factors🔍
- Clinical Characteristics and Outcomes in Patients With Coronavirus ...🔍
- Multiple sclerosis and COVID‐19🔍
Modifiable Risk Factors of COVID|19 in Patients with Multiple Sclerosis
Modifiable risk factors of COVID-19 in patients with multiple sclerosis
Disease and treatment-associated immune system abnormalities may confer higher risk of Coronavirus disease 2019 (COVID-19) to people with multiple sclerosis ( ...
Modifiable risk factors of COVID-19 in patients with multiple sclerosis
Results. MS-COVID and MS-NCOVID were similar in terms of age, sex, disease duration, EDSS, clinical phenotype and treatment. At multiple ...
Modifiable Risk Factors of COVID-19 in Patients with Multiple Sclerosis
This case-control study underlines the importance of constant monitoring and supplementation of Vitamin D in PwMS.
Underlying Conditions and the Higher Risk for Severe COVID-19
Age is the strongest risk factor for severe COVID-19 outcomes. Patients with one or multiple certain underlying medical conditions are also at ...
Risk of Getting COVID-19 in People With Multiple Sclerosis
The potential role of disease-modifying therapies (DMTs) and demographic and clinical factors on the risk of acquiring SARS-CoV-2 infection has ...
SARS-CoV-2 Infection in a North American Registry of Patients With ...
This cross-sectional study examines outcomes and risk factors associated with COVID-19 clinical severity in a large, diverse cohort of North ...
Modifiable risk factors of COVID-19 in patients with multiple sclerosis
Background Disease and treatment-associated immune system abnormalities may confer higher risk of Coronavirus disease 2019 (COVID-19) to ...
Multiple Sclerosis and COVID-19 Risk Factors - Healthline
People with MS aren't at an increased risk of contracting COVID-19. However, some factors may put them at a higher risk of serious illness.
Modifiable Risk Factors of COVID-19 in Patients with Multiple Sclerosis
Request PDF | On Apr 28, 2023, Federico Montini and others published Modifiable Risk Factors of COVID-19 in Patients with Multiple Sclerosis: A ...
Prevalence, severity, outcomes, and risk factors of COVID-19 in ...
Among MS patients, those who belong to an older age group or have a more progressive form of the disease have been shown to develop complications in addition to ...
Clinical Characteristics and Outcomes in Patients With Coronavirus ...
... (COVID-19) in patients with multiple sclerosis (MS)?. Findings In this cohort study of 347 patients with MS, risk factors ... modify the risk ...
Modifiable risk factors of COVID-19 in patients with multiple sclerosis
Request PDF | Modifiable risk factors of COVID-19 in patients with multiple sclerosis: a single-centre case–control study | Background ...
Multiple sclerosis and COVID‐19: How many are at risk?
The coronavirus disease 2019 (COVID-19) pandemic challenges neurologists in counseling multiple sclerosis (MS) patients with respect to their ...
Modifiable risk factors of COVID-19 in patients with multiple sclerosis
We assessed modifiable risk factors associated with COVID-19 in PwMS. Methods. Among patients referring to our MS Center, we retrospectively ...
a nested case–control study in an English population-based cohort
Established modifiable risk factors for multiple sclerosis—smoking, obesity, infectious mononucleosis, low vitamin D, and head injury—were ...
Modifiable Risk Factors in the Progression of Multiple Sclerosis
Other subtypes of MS include secondary progressive MS (patients develop relapsing-remitting MS but then begin progressing with or without relapses). In about 50 ...
Modifiable risk factors of COVID-19 in patients with multiple sclerosis
Case control analysis with 149 multiple sclerosis patients and 292 matched controls in Italy, showing lower risk of COVID-19 cases with higher vitamin D ...
Environmental modifiable risk factors for multiple sclerosis
A few preliminary clinical studies with helminth therapy have been conducted in MS patients. A small controlled trial of Trichuris suis ova failed to show any ...
The Importance of Managing Modifiable Comorbidities in People ...
... 19,20]. Comorbid conditions exacerbate the disability ... Modifiable comorbidities and risk factors in people with multiple sclerosis (MS).
An investigation of the risk factors associated with falls in people ...
This study confirmed the high prevalence of falls in ambulant people with MS. Important potentially modifiable risk factors are identified, suggesting aspects ...